Cornerstone Wealth Group LLC Has $6.19 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Cornerstone Wealth Group LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,230 shares of the healthcare conglomerate’s stock after purchasing an additional 190 shares during the quarter. Cornerstone Wealth Group LLC’s holdings in UnitedHealth Group were worth $6,187,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. KBC Group NV boosted its position in shares of UnitedHealth Group by 4.1% during the 4th quarter. KBC Group NV now owns 918,316 shares of the healthcare conglomerate’s stock valued at $464,539,000 after acquiring an additional 35,973 shares in the last quarter. Union Bancaire Privee UBP SA acquired a new stake in UnitedHealth Group during the fourth quarter valued at approximately $27,233,000. Capital Asset Advisory Services LLC raised its holdings in shares of UnitedHealth Group by 11.5% in the 4th quarter. Capital Asset Advisory Services LLC now owns 7,343 shares of the healthcare conglomerate’s stock worth $3,767,000 after buying an additional 760 shares in the last quarter. Blue Trust Inc. grew its position in UnitedHealth Group by 34.4% in the fourth quarter. Blue Trust Inc. now owns 14,013 shares of the healthcare conglomerate’s stock valued at $7,089,000 after acquiring an additional 3,584 shares during the period. Finally, Drive Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 4.6% during the fourth quarter. Drive Wealth Management LLC now owns 3,068 shares of the healthcare conglomerate’s stock valued at $1,552,000 after acquiring an additional 135 shares during the period. 87.86% of the stock is owned by institutional investors.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Up 0.5 %

Shares of NYSE UNH opened at $532.26 on Monday. The firm has a 50 day moving average price of $541.04 and a 200 day moving average price of $564.34. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market cap of $489.83 billion, a P/E ratio of 34.34, a P/E/G ratio of 1.41 and a beta of 0.62. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the firm earned $5.83 earnings per share. The company’s revenue was up 6.8% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post 29.74 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.58%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is presently 54.19%.

Analyst Upgrades and Downgrades

UNH has been the subject of several analyst reports. Bank of America cut their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. UBS Group cut their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Finally, Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group has an average rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.